PUBLICATIONS

Sundaram M, Qi Y, Shriver Z, Liu D, Zhao G, Venkataraman G, Langer R, and Sasisekharan R. (2003) Rational design of low molecular weight heparins with improved in vivo activity. Proc. Natl. Acad. Sci. USA, 100, 651–6.

Editorial Commentary (2002): Six blind men and the elephant — The many faces of heparan sulfate. Proc. Natl. Acad. Sci. USA, 99, 543–5.

Liu D, Shriver Z, Venkataraman G, El Shabrawi Y, and Sasisekharan R. (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA, 99, 568–73.

Keiser N, Venkataraman G, Shriver Z, and Sasisekharan R. (2001) Direct isolation and sequencing of specific protein-binding glycosaminoglycans. Nature Medicine, 7, 123–128.

Editorial Commentary (2000): Heparin sequencing brings structure to the function of complex oligosaccharides. Proc. Natl. Acad. Sci. USA, 97, 10301–10303.

Venkataraman G, Shriver Z, Raman R, and Sasisekharan R. (1999) Sequencing complex polysaccharides. Science, 286, 537–542.

Shriver Z, Raman R, Venkataraman G, Drummond K, Turnbull J, Toida, T, Linhardt R, Biemann K, and Sasisekharan R. (2000) Sequencing of 3-O sulfate containing decasaccharides with a partial antithrombin III binding site. Proc. Natl. Acad. Sci. USA, 97(19), 10359–10364.

Sasisekharan R, Shriver Z, Venkataraman G, and Narayanaswamy U. (2002) Roles of heparan sulfate glycosaminoglycans in cancer. Nat. Rev. Cancer, 2, 521–8